POPular ACE TAVI
2026
Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation
In 966 patients undergoing transfemoral TAVI, routine protamine after the procedure reduced death or bleeding at 30 days compared with selective protamine.
Résultat
Critère principal: composite of all-cause mortality or clinically relevant bleeding (VARC-3 type 1–4) within 30 days after TAVI
Death or clinically relevant bleeding at 30 days: risk difference −10.9 percentage points (95% CI −17.0 to −4.8; P < 0.001) in favour of routine protamine. The difference is carried by minor bleeding (type 1: −10.9 points, 95% CI −16.8 to −5.1). Anaphylaxis was more frequent with routine protamine: +1.3 points (95% CI 0.2 to 3.0; P = 0.01).
- Sous-thème
- TAVR protamine
- Schéma
- investigator-initiated, multicentre (6 sites, Netherlands and Belgium), double-blind, placebo-controlled RCT; 1:1 routine vs selective protamine, stratified by site and antithrombotic therapy; 30-day follow-up
- Inclus
- 1 000 patients
- Pertinence
- Important: l’un des piliers parmi d’autres.
- Source
- Overduin C, et al. Presented at ESC Congress 2026, Hot Line 7, 30 August.
Discussion et critique
Reversing heparin before pulling a large-bore sheath removes about one bleeding event in nine, which is a large effect for a cheap drug given at the end of a routine procedure. The whole of that effect sits in VARC type 1 bleeding: the minor kind, an ooze or a haematoma rather than a transfusion, so the composite reads stronger than the clinical gain is. Against it stands anaphylaxis in 1.3% more patients, rare but the one complication that can be worse than the bleeding avoided; the trade is favourable on average and worth naming in the consent.